MetaCap

Processa Pharmaceuticals Insider Trades

NASDAQ: PCSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.56-0.13 (-7.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
26 · $130.87K
Sales
0 · $0
Shares bought / sold
53.74K / 0
Net activity
Net buying $130,867

Processa Pharmaceuticals insider activity

Over the last 12 months, Processa Pharmaceuticals insiders reported 31 transactions on SEC Form 4: 26 open-market purchases and 0 sales. Insiders bought $130,867 and sold $0 worth of stock, for net insider buying of $130,867. The most recent filing shows Ng George K (Chief Executive Officer) reporting a transaction in 1,600 shares on Aug 8, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PCSA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PCSA insider transactions

Processa Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Aug 8, 2026Ng George KChief Executive OfficerOption exercise1,600—Form 4
Jul 1, 2026Ng George KChief Executive OfficerBuy3,057$5.90KForm 4
Jun 30, 2026Young DavidPres. Research & DevelopmentBuy2,531$4.88KForm 4
Jun 30, 2026SKIBSTED RUSSELLChief Financial OfficerBuy3,277$6.32KForm 4
Jun 30, 2026Lin PatrickChief Business - Strategy OffBuy2,106$4.06KForm 4
Jun 30, 2026Guy WendyChief Administrative OfficerBuy2,436$4.70KForm 4
Jun 26, 2026Pannu GeraldineDirectorOption exercise203—Form 4
Jun 26, 2026Yorke Justin WDirectorOption exercise203—Form 4
Jun 26, 2026Baluch KhosoDirectorOption exercise203—Form 4
Jun 26, 2026Neal James RDirectorOption exercise203—Form 4
Jun 15, 2026Guy WendyChief Administrative OfficerBuy2,118$4.70KForm 4
Jun 15, 2026Ng George KChief Executive OfficerBuy2,465$5.47KForm 4
Jun 15, 2026SKIBSTED RUSSELLChief Financial OfficerBuy2,654$5.89KForm 4
Jun 15, 2026Lin PatrickChief Business - Strategy OffBuy1,831$4.06KForm 4
Jun 15, 2026Young DavidPres. Research & DevelopmentBuy2,067$4.59KForm 4
May 29, 2026Young DavidPres. Research & DevelopmentBuy1,786$4.59KForm 4
May 29, 2026Lin PatrickChief Business - Strategy OffBuy1,582$4.07KForm 4
May 29, 2026Ng George KChief Executive OfficerBuy2,129$5.47KForm 4
May 29, 2026Guy WendyChief Administrative OfficerBuy1,829$4.70KForm 4
May 29, 2026SKIBSTED RUSSELLChief Financial OfficerBuy2,292$5.89KForm 4
May 15, 2026SKIBSTED RUSSELLChief Financial OfficerBuy1,984$5.89KForm 4
May 15, 2026Lin PatrickChief Business - Strategy OffBuy1,369$4.07KForm 4
May 15, 2026Ng George KChief Executive OfficerBuy1,843$5.47KForm 4
May 15, 2026Guy WendyChief Administrative OfficerBuy1,583$4.70KForm 4
May 15, 2026Young DavidPres. Research & DevelopmentBuy1,545$4.59KForm 4
Apr 30, 2026Ng George KChief Executive OfficerBuy2,034$5.47KForm 4
Apr 30, 2026SKIBSTED RUSSELLChief Financial OfficerBuy2,190$5.89KForm 4
Apr 30, 2026Young DavidPres. Research & DevelopmentBuy1,706$4.59KForm 4
Apr 30, 2026Lin PatrickChief Business - Strategy OffBuy1,511$4.06KForm 4
Apr 30, 2026Bigora SianChief Development OfficerBuy1,971$5.34KForm 4
Apr 15, 2026Ng George KChief Executive OfficerBuy1,843$5.47KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related